Stay updated on Pembrolizumab+Lenvatinib vs Chemo in Endometrial Carcinoma Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab+Lenvatinib vs Chemo in Endometrial Carcinoma Clinical Trial page.

Latest updates to the Pembrolizumab+Lenvatinib vs Chemo in Endometrial Carcinoma Clinical Trial page
- Check5 days agoNo Change Detected
- Check12 days agoChange DetectedA new revision v3.6.5 was added to the study record history, replacing the previous v3.6.4, indicating a metadata update to the record's version history.SummaryDifference0.0%

- Check19 days agoNo Change Detected
- Check26 days agoChange DetectedThe page’s revision line in the history was updated from v3.6.3 to v3.6.4, indicating a new release entry has been recorded for the study history. This change reflects an internal version update rather than a modification to study content.SummaryDifference0.0%

- Check48 days agoChange DetectedThe page's revision tag was updated from v3.6.2 to v3.6.3, indicating an updated version of the record history display.SummaryDifference0.0%

- Check55 days agoChange DetectedThe page footer revision indicator updated from v3.6.0 to v3.6.2. This represents a small platform/UI update rather than any changes to the study information or user interactions.SummaryDifference0.0%

- Check69 days agoChange DetectedA new revision entry v3.6.0 has been added, and the recruitment note 'No longer looking for participants' has been added to the record. The previous revision v3.5.5 has been removed.SummaryDifference0.1%

- Check77 days agoChange DetectedThe page now shows Revision: v3.5.5 instead of v3.5.4, reflecting a new site release. This change updates the page metadata without altering study content.SummaryDifference0.0%

Stay in the know with updates to Pembrolizumab+Lenvatinib vs Chemo in Endometrial Carcinoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab+Lenvatinib vs Chemo in Endometrial Carcinoma Clinical Trial page.